{"protocolSection":{"identificationModule":{"nctId":"NCT03085576","orgStudyIdInfo":{"id":"DAC-001-NATUREAF"},"organization":{"fullName":"Dacima Consulting","class":"OTHER"},"briefTitle":"NATional TUnisian REgistry of Atrial Fibrillation","officialTitle":"National Tunisian Registry of Atrial Fibrillation","acronym":"NATURE-AF"},"statusModule":{"statusVerifiedDate":"2021-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-03-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-05-30","type":"ACTUAL"},"completionDateStruct":{"date":"2018-07-30","type":"ACTUAL"},"studyFirstSubmitDate":"2017-03-05","studyFirstSubmitQcDate":"2017-03-14","studyFirstPostDateStruct":{"date":"2017-03-21","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-04-27","lastUpdatePostDateStruct":{"date":"2021-04-29","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Dacima Consulting","class":"OTHER"},"collaborators":[{"name":"Société Tunisienne de Cardiologie & de Chirurgie Cardio-Vasculaire","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"A non-interventional, national longitudinal study of atrial fibrillation performed with 91 cardiologists.","detailedDescription":"The NATURE-AF study is carried out in Tunisia at cardiology consultations in hospitals and in the liberal sector. A total of 91 cardiologists participate in the selection of patients as investigators. The study is a longitudinal non-interventional registry of atrial fibrillation. The data collected are managed by the DACIMA Clinical Suite® platform, which complies with international standards: FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPPA (Health Insurance Portability and Accountability Act), ICH (International Conference on Harmonisation), MedDRA (Medical Dictionary for Regulatory Activities). The DACIMA Clinical Suite® platform allows to track the data entered, check for inconsistencies and missing data, and schedule monitoring visits. A Steering Committee is set up to monitor patient inclusions, verify data sources, perform audit trails and prepare the statistical analysis plan for the study."},"conditionsModule":{"conditions":["Atrial Fibrillation"],"keywords":["Atrial Fibrillation","Anticoagulation","Stroke","Vitamin K antagonist","Cardioversion","INR (International Normalized Ratio)"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"12 Months","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":910,"type":"ACTUAL"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Incidence of stroke or transient ischemic attack, thromboembolic events and cardiovascular death","description":"Number of patients with ischemic stroke and/or transient ischemic attack, and/or arterial embolization during the follow-up period","timeFrame":"Every 3 months up to 1 year"}],"secondaryOutcomes":[{"measure":"Haemorrhagic accidents","description":"All bleeding events (digestive, cerebral, other locations)","timeFrame":"Every 3 months up to 1 year"},{"measure":"Measurement of INR (International Normalized Ratio)","description":"INR measurement of venous blood sampling","timeFrame":"Every month for 1 year"},{"measure":"TTR (percent Time in Therapeutic INR Range)","description":"The mean TTR obtained in patients who received anticoagulant therapy","timeFrame":"1 year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* At least one episode of atrial fibrillation, documented on a 12-lead ECG and / or a rhythmic holter (duration of the episode: 30 seconds or more)\n* Recent atrial fibrillation diagnosed for less than a year\n* Regular monitoring every 3 months is ensured\n* Informed, read and signed consent\n\nExclusion Criteria:\n\n* Estimated life expectancy at less than 12 months\n* Transient atrial fibrillation due to reversible cause (eg acute myocardial infarction, following cardiac surgery, acute alcohol intoxication, hyperthyroidism, pulmonary embolism or other acute pulmonary disease, pericarditis, myocarditis, hydro-electrolyte disorder, metabolic disorder)\n* Cardiac surgery ≤ 3 months\n* Atrial flutter isolated without atrial fibrillation\n* Mental disorders\n* Ongoing anticoagulation for reasons other than atrial fibrillation","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients with atrial fibrillation","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Faouzi Addad, Professor","affiliation":"Société Tunisienne de Cardiologie et de Chirurgie Cardiovasculaire","role":"STUDY_CHAIR"}],"locations":[{"facility":"STCCCV - Société Tunisienne de Cardiologie et de Chirurgie Cardio-Vasculaire","city":"Tunis","zip":"1053","country":"Tunisia","geoPoint":{"lat":36.81897,"lon":10.16579}}]},"referencesModule":{"references":[{"pmid":"30322836","type":"BACKGROUND","citation":"Ben Halima A, Ouali S, Mourali MS, Chabrak S, Chettaoui R, Ben Halima M, Haggui A, Larbi N, Krichene S, Marrakchi S, Kacem S, Chrigui R, Abbes MF, Baccar H, Baraket N, Ben Halima N, Ben Khalfallah A, Ben Mbarek M, Ben Youssef S, Boughzala E, Boujnah MR, Drissa H, Gamra H, Gasmi A, Haouala H, Harrath Y, Issa I, Jeridi G, Kachboura S, Kammoun S, Kraiem S, Maatouk F, Milouchi S, Nasraoui W, Neji A, Sayahi K, Sdiri W, Smati W, Tlili S, Abid L, Abdesselem S, Zakhama L, Mahdhaoui A, Kammoun H, Ben Omrane S, Addad F. Design and Rationale of the National Tunisian Registry of Atrial Fibrillation: Protocol for a Prospective, Multicenter Trial. JMIR Res Protoc. 2018 Oct 15;7(10):e181. doi: 10.2196/resprot.8523."},{"pmid":"33704830","type":"BACKGROUND","citation":"Ouali S, Ben Halima A, Chabrak S, Chettaoui R, Ben Halima M, Haggui A, Krichane S, Noureddine L, Marrakchi S, Charfeddine S, Hassine M, Sayahi K, Abbes Mohamed F, Nasraoui W, Ajmi H, Ben Miled M, Jebbari Z, Meghaieth MA, Allouche E, Mechmeche R, Zakhama L, Sdiri W, Ben Khalfallah A, Gharbi A, Milouchi S, Neji A, Antit S, Battikh K, Drissa M, Kaabachi S, Najar T, Tlili R, Chahbani I, Charfeddine H, Ben MM, Braham S, Maatouk F, Abdesselem S, Ayari M, Garbaa R, Hamrouni N, Mbarek D, Rekik H, Zaghdoudi H, Ayadi W, Baraket F, Ben Brahim K, Ben Romdhane M, Bousadia H, Brahim W, Mezri M, Guesmi A, Ounissi T, Kammoun S, Smati W, Tlili S, Zoughi K, Zemni J, Cheikh Bouhlel M, Islem S, Jemli R, Joulak A, Mzoughi K, Naanea H, Hached L, Hadrich M, Hmem M, Kacem S, Kammoun I, Othmani R, Ouerghi A, Abid S, Ennouri R, Haidar S, Heraiech S, Jammali M, Jarrar M, Riahi L, Trimech B, Azaiez MA, Azzouzi F, Ben Jemaa K, Ben Rejab O, Chrigui R, Wechtati W, Boughzela E, Jridi G, Bezdah L, Kraiem S, Drissa H, Ben Youssef S, Fehri W, Kachboura S, Gamra H, Kammoun S, Mourali MS, Addad F, Abid L. Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE-AF). Clin Cardiol. 2021 Apr;44(4):501-510. doi: 10.1002/clc.23558. Epub 2021 Mar 11."}],"seeAlsoLinks":[{"label":"Medscape : A first register on AF in the Maghreb","url":"https://francais.staging.medscape.com/voirarticle/3606891?fbclid=IwAR1CgOQVZhdvIgVnI-ENiCMDIYgc2x22NF7GFcdj7_rADztgmccRwc6Stgc"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M17245","name":"Vitamin K","relevance":"LOW"},{"id":"M17248","name":"Vitamins","relevance":"LOW"},{"id":"T481","name":"Vitamin K","relevance":"LOW"},{"id":"T450","name":"Menaquinone","relevance":"LOW"},{"id":"T449","name":"Menadione","relevance":"LOW"},{"id":"T452","name":"Naphthoquinone","relevance":"LOW"},{"id":"T458","name":"Phylloquinone","relevance":"LOW"}],"browseBranches":[{"abbrev":"Micro","name":"Micronutrients"},{"abbrev":"Coag","name":"Coagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Vi","name":"Vitamins"}]}},"hasResults":false}